Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update-Reference-Cited by-同舟云学术

Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update

Published:2021-12 Issue: Volume:168 Page:103533
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Nervo Alice^ORCID,Retta Francesca^ORCID,Ragni Alberto,Piovesan Alessandro^ORCID,Mella Alberto,Biancone Luigi,Manganaro Marco^ORCID,Gallo Marco^ORCID,Arvat Emanuela

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference101 articles.

1. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma;Abou-Alfa;N. Engl. J. Med.,2018

2. Acute kidney injury by radiographic contrast media: pathogenesis and prevention;Andreucci;BioMed Res. Int.,2014

3. Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition;Bai;Kidney Int.,2021

4. Lenvatinib in advanced radioiodine-refractory thyroid cancer - a retrospective analysis of the swiss lenvatinib named patient program;Balmelli;J. Cancer,2018

5. Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study;Bible;Lancet Oncol.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in targeted therapy and biomarker research in thyroid cancer;Frontiers in Endocrinology;2024-03-04

2. From Rare Disorders of Kidney Tubules to Acute Renal Injury: Progress and Prospective;Kidney Diseases;2024

3. Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper;ESMO Open;2023-12

4. Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm;European Thyroid Journal;2023-04-25

5. Role for calcineurin inhibitor in tyrosine kinase inhibitor-induced focal segmental glomerulosclerosis;Journal of Onco-Nephrology;2023-02-22